Sensorion announces that it is not impacted by the closure of Silicon Valley Bank
Montpellier, March 13, 2023 – Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of gene therapies for the ear, has learned that Silicon Valley Bank (SVB) has been closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as receiver.
Sensorion does not expect any impact on its liquidity position or on its ongoing operations as a result of the bankruptcy of SVB.